Plasminogen activator inhibitor 1 (PAI-1) deficiency in pregnancy.

被引：0
|
作者：
Morganstein, N
Miller, CH
Saidi, P
Philipp, CS
机构：
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2008
引用
收藏
页码：547A / 547A
页数：1
相关论文
共 50 条
  • [31] Mechanistic studies on the inactivation of plasminogen activator inhibitor 1 (PAI-1) by the small molecule PAI-1 antagonist PAI-749
    Gardell, SJ
    Antrilli, TM
    Elokdah, H
    Krueger, JA
    Mayer, S
    Orcutt, SJ
    Vlasuk, GP
    Crandall, DL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E104 - E104
  • [32] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    DIABETES, 1994, 43 : A197 - A197
  • [33] TISSUE CONCENTRATIONS OF THE MAJOR INHIBITOR OF PLASMINOGEN-ACTIVATOR, PAI-1
    BOOTH, NA
    BENNETT, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (01) : 134 - 134
  • [34] Mechanistic Studies on the Inactivation of Plasminogen Activator Inhibitor (PAI-1) by PAI-749, a Small Molecule PAI-1 Antagonist
    Gardell, S.
    Antrilli, T.
    Elokdah, H.
    Krueger, J.
    Mayer, S.
    Orcutt, S.
    Vlasuk, G.
    Crandall, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 169 - 169
  • [35] Deficiency of plasminogen activator inhibitor-1 (PAI-1) enhances glucose uptake in primary adipocytes.
    Kanjanabuch, T
    Mao, S
    Chen, JK
    Pozzi, A
    Hoover, R
    McGuinness, OP
    Wasserman, DH
    Fogo, AB
    Ma, LJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 391A - 391A
  • [36] Plasminogen activator inhibitor-1 (PAI-1) is an endogenous inhibitor of retinal neovascularization.
    Ando, A
    Mori, K
    Yamada, H
    Yamada, E
    Campochiaro, PA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S537 - S537
  • [37] The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals
    Verschuur, M
    Jellema, A
    Bladbjerg, EM
    Feskens, EJM
    Mensink, RP
    Moller, L
    Vos, HL
    de Maat, MPM
    ATHEROSCLEROSIS, 2005, 181 (02) : 275 - 284
  • [38] Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients
    Kowal, Krzysztof
    Zukowski, Sebastian
    Moniuszko, Marcin
    Bodzenta-Lukaszyk, Anna
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (02) : 193 - 198
  • [39] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    CIRCULATION, 1990, 82 (04) : 601 - 601
  • [40] Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1)
    Lademann, Ulrik A.
    Romer, Maria Unni
    THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) : 1041 - 1046
12345